Track And Trace Systems Under Negotiations In India To Protect Industry Reputation
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Pharmaceutical goods exported from India will be subject to intense scrutiny as government agencies kick off negotiations with industry stakeholders to adopt suitable tracing and tracking technologies to establish the genuineness of drugs manufactured in India
You may also be interested in...
India Plans Tighter Enforcement At State Level To Counter Spread Of Spurious Drugs
India plans to step-up enforcement as some generic drug manufacturers continue to take shortcuts, ignoring the prospect of harsh penalties under a law passed two years ago.
Record Drug Recall Totals for 2009 Resulted from GMP Breakdowns
A deluge of drug recalls set a record in 2009. With the past four years now among the top five for recalls, it suggests drug quality could be in a period of decline. Last year's record reflects GMP breakdowns at a drug repacker and several manufacturers that were identified during FDA inspections and led to a variety of sanctions, including warning letters, consent decrees and an import alert. Congress is looking to let FDA mandate recalls, which means the rain of recalls could grow even heavier. Meanwhile, FDA adds suspensions to its enforcement arsenal. International recalls remain rare, though that could change as FDA ramps up enforcement abroad
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).